Maricopa Arizona Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Maricopa
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Maricopa Arizona Collateral License Agreement is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center, which outlines the terms and conditions for the use of collateral and intellectual property. This agreement grants Gentling, Inc. the right to utilize any collateral assets owned by The University of North Texas Health Science Center for the purpose of commercializing or further developing products or technologies. This includes but is not limited to patents, trademarks, copyrights, trade secrets, and other proprietary information. The main objective of the Maricopa Arizona Collateral License Agreement is to establish a mutually beneficial relationship between Gentling, Inc. and The University of North Texas Health Science Center. It allows Gentling, Inc. to access the university's resources and research findings to advance their scientific and technological endeavors. The agreement provides a framework for the transfer of knowledge and technology, enabling Gentling, Inc. to develop innovative solutions and products based on the joint efforts of the company and the university. In return, The University of North Texas Health Science Center may receive financial compensation, royalties, or other benefits outlined in the agreement. Different types of Maricopa Arizona Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center may include specific provisions based on the nature of the collateral assets involved. For example, there could be agreements related to patent licensing, where Gentling, Inc. obtains the rights to use patented technologies developed by the university. Alternatively, there may be agreements related to trademark licensing, where specific brand names or logos are licensed for use by Gentling, Inc. The terms and conditions of each Maricopa Arizona Collateral License Agreement may vary and are negotiated between the parties involved. These agreements define the scope of use, duration, financial arrangements, confidentiality, dispute resolution, termination clauses, and any other relevant provisions necessary to ensure the rights and obligations of both Gentling, Inc. and The University of North Texas Health Science Center are clearly stated and protected. Overall, the Maricopa Arizona Collateral License Agreement plays a crucial role in facilitating collaboration between Gentling, Inc. and The University of North Texas Health Science Center, promoting innovation, and fostering the commercialization of intellectual property for the benefit of both parties.

Maricopa Arizona Collateral License Agreement is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center, which outlines the terms and conditions for the use of collateral and intellectual property. This agreement grants Gentling, Inc. the right to utilize any collateral assets owned by The University of North Texas Health Science Center for the purpose of commercializing or further developing products or technologies. This includes but is not limited to patents, trademarks, copyrights, trade secrets, and other proprietary information. The main objective of the Maricopa Arizona Collateral License Agreement is to establish a mutually beneficial relationship between Gentling, Inc. and The University of North Texas Health Science Center. It allows Gentling, Inc. to access the university's resources and research findings to advance their scientific and technological endeavors. The agreement provides a framework for the transfer of knowledge and technology, enabling Gentling, Inc. to develop innovative solutions and products based on the joint efforts of the company and the university. In return, The University of North Texas Health Science Center may receive financial compensation, royalties, or other benefits outlined in the agreement. Different types of Maricopa Arizona Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center may include specific provisions based on the nature of the collateral assets involved. For example, there could be agreements related to patent licensing, where Gentling, Inc. obtains the rights to use patented technologies developed by the university. Alternatively, there may be agreements related to trademark licensing, where specific brand names or logos are licensed for use by Gentling, Inc. The terms and conditions of each Maricopa Arizona Collateral License Agreement may vary and are negotiated between the parties involved. These agreements define the scope of use, duration, financial arrangements, confidentiality, dispute resolution, termination clauses, and any other relevant provisions necessary to ensure the rights and obligations of both Gentling, Inc. and The University of North Texas Health Science Center are clearly stated and protected. Overall, the Maricopa Arizona Collateral License Agreement plays a crucial role in facilitating collaboration between Gentling, Inc. and The University of North Texas Health Science Center, promoting innovation, and fostering the commercialization of intellectual property for the benefit of both parties.